Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Trichotillomania was successfully treated with risperidone and naltrexone.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Nutrafol might help reduce hair loss due to inflammation, but more evidence is needed.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

A woman's hair loss looked like a different condition due to her hairstyle, and treatment stopped further hair loss but didn't regrow hair.

Antiandrogen therapy is effective and well tolerated for treating women's androgenic disorders like hirsutism, acne, and hair loss.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Scalp micropigmentation is a successful, non-surgical way to make hair look fuller.

The Broad Ligament Maneuver effectively relieved PCOS symptoms and restored ovarian function.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Many Chinese patients lose hair after weight loss surgery, especially women, and taking iron and zinc on their own doesn't help.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Both surgical hairline advancement and follicular unit transplantation effectively lower the female hairline, but they differ in speed, scarring, and naturalness of results.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Anticonvulsant drugs may cause temporary chromosomal abnormalities.

The herbal mix effectively treats PCOS and can be sold for this use.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

New lipid nanoparticles show promise for delivering hair loss treatments but need improvement for better skin penetration.

Formononetin, found in red clover plants, can promote hair regrowth and reduce hair loss by preventing cell death.

The KNU implanter for hair transplants showed a high survival rate of 90%+ for transplanted hairs after 6 months, with benefits like natural hair direction and fewer scars.

Finasteride helps induce ovulation in nonresponder PCOS women.

Spironolactone does not change hair growth.